Deutsche Bank boosts Acadia Pharmaceuticals Rating to “Buy” BUCHAREST – May 3, 2024 – Deutsche Bank’s upgrade of Acadia pharmaceuticals to a “Buy” rating on May 21, 2025, has sparked significant interest. This strategic move reflects a positive outlook on the company’s trajectory. Deutsche Bank’s assessment is being closely scrutinized as investors assess Acadia Pharmaceuticals’ … Read more
You can read the full story here: Deutsche Bank Boosts ACADIA Pharmaceuticals Stock: LSE:0A4W .